相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Different 8-Hydroxyquinolines Protect Models of TDP-43 Protein, α-Synuclein, and Polyglutamine Proteotoxicity through Distinct Mechanisms
Daniel F. Tardiff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity
Peter J. Crouch et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan
Silvestre Alavez et al.
NATURE (2011)
Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease
Erik Portelius et al.
ACTA NEUROPATHOLOGICA (2010)
The Caenorhabditis elegans Aβ1-42 Model of Alzheimer Disease Predominantly Expresses Aβ3-42
Gawain Mccoll et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?
Dawn Teschendorf et al.
MOLECULAR NEURODEGENERATION (2009)
Intracellular amyloid formation in muscle cells of Aβ-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification
Alicia N. Minniti et al.
MOLECULAR NEURODEGENERATION (2009)
Stabilization of neurotoxic soluble β-sheet-rich conformations of the Alzheimer's disease amyloid-β peptide
Deborah J. Tew et al.
BIOPHYSICAL JOURNAL (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ
Paul A. Adlard et al.
NEURON (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Solution state characterization of amyloid β-derived diffusible ligands
Robert W. Hepler et al.
BIOCHEMISTRY (2006)
Opposing activities protect against age-onset proteotoxicity
Ehud Cohen et al.
SCIENCE (2006)
Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity
Anthony R. White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Improved prediction of signal peptides: SignalP 3.0
JD Bendtsen et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1-42) in a transgenic Caenorhabditis elegans model
J Drake et al.
NEUROBIOLOGY OF AGING (2003)
daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans
ST Henderson et al.
CURRENT BIOLOGY (2001)
Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34
CD Link et al.
NEUROBIOLOGY OF AGING (2001)
X-34, a fluorescent derivative of Congo red: A novel histochemical stain for Alzheimer's disease pathology
SC Styren et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
分享论文
